Takeda Pharmaceutical Company Limited completes its previously-announced sale of a portfolio of select products to Celltrion Inc... Dec 01
Celltrion launches post-exposure prophylaxis clinical trial of anti-COVID-19 monoclonal antibody treatment candidate, CT-P59 ... Oct 15
Celltrion has research experience with other types of coronavirus conditions such as Middle East Respiratory Syndrome (MERS)... Jun 01
-Advertisements-